Skip to main content
SpringerLink
Log in

Collagenase: Future Perspectives

  • Chapter
  • First Online:
Collagenase in Dupuytren Disease

Abstract

Collagenase Clostridium histolyticum (CCH) was introduced in 2009 [1] and was approved by the FDA for use in the United States under the name Xiaflex® for the treatment among adults with a palpable Dupuytren’s cord, on February 2, 2010.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase clostridium histolyticum for Dupuytren’s contracture. N Engl J Med. 2009;361(10):968–97.

    Article  CAS  PubMed  Google Scholar 

  2. Gelbard M, Goldstein I, Hellström WJ, McMahon CH, Smith T, Tursi J, Jones N, Kaufman GJ, Carson CC. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190(1):199–207.

    Article  CAS  PubMed  Google Scholar 

  3. Coleman S, Gilpin D, Kaplan FT, Houston A, Kaufman GJ, Cohen BM, Jones N, Tursi JP. Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures. J Hand Surg Am. 2014;39:57–64.

    Article  PubMed  Google Scholar 

  4. Gelbermann RH, Amiel D, Rudolph RM, et al. Dupuytren’s contracture of the Plantar fascia. J Bone Joint Surg Am. 1980;62A:425–32.

    Article  Google Scholar 

  5. Traore EJ, Wang W, Yafi FA, Hellstrom WJ. Collagenase Clostridium histolyticum in the management of Peyronie’s disease: a review of the evidence. Ther Adv Urol. 2016;8(3):192–202.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Veith NT, Tschernig T, Histing T, Madry H. Plantar fibromatosis--topical review. Foot Ankle Int. 2013;34(12):1742–6.

    Article  PubMed  Google Scholar 

  7. Hammoudeh ZS. Collagenase Clostridium histolyticum injection for plantar fibromatosis (Ledderhose disease). Plast Reconstr Surg. 2014;134(3):497e–8e.

    Article  CAS  PubMed  Google Scholar 

  8. Luck V. Dupuytren’s contracture. A new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg. 1959;41:635–64.

    Article  PubMed  Google Scholar 

  9. Meek RMD, McClellan S, Reilly J, et al. The effect of steroids on Dupuytren’s disease: role of programmed cell death. J Hand Surg. 2002;27:270–3.

    Article  CAS  Google Scholar 

  10. Ketchum LD, Donahue TK. The injection of nodules of Dupuytren’s disease with triamcinolone acetonide. J Hand Surg. 2000;25A:1157–62.

    Article  Google Scholar 

  11. Manske RC, Prohaska D. Diagnosis and management of adhesive capsulitis. Curr Rev Musculoskelet Med. 2008;1(3-4):180–9.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Bulgen DY, Binder A, Hazeman BL, et al. Immunological studies in frozen shoulder. J Rheumatol. 1992;9(6):893–8.

    Google Scholar 

  13. Badalamente MA, Wang ED. CORR®ORS Richard A. Brand award: clinical trials of a new treatment method for adhesive capsulitis. Clin Orthop Relat Res. 2016;474(11):2327–36.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Tamboto H, Vicjery K, Deva AK. Subclinical (biofilm) infection causes capsular contracture in a porcine model following augmentation mammoplasty. Plast Reconstr Surg. 2010;126(3):835–42.

    Article  CAS  PubMed  Google Scholar 

  15. Fischer S, Hirche C, Diehm Y, Nuutila K, Kiefer J, Gazyakan E, Bueno EM, Kremer T, Kneser U, Pomahac B. Efficacy and safety of the collagenase of the Bacterium Clostridium histolyticum for the treatment of capsular contracture after silicone implants: ex-vivo study on human tissue. PLoS One. 2016;11(5):e0156428.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Kang N, Sivakumar B, Sanders R, Nduka C, Gault D. Intra-lesional injections of collagenase are ineffective in the treatment of keloid and hypertrophic scars. J Plast Reconstr Aesthet Surg. 2006;59(7):693–9.

    Article  PubMed  Google Scholar 

  17. Bae-Harboe YS, Harboe-Schmidt JE, Graber E, Gilchrest BA. Collagenase followed by compression for the treatment of earlobe keloids. Dermatol Surg. 2014;40(5):519–24.

    Article  CAS  PubMed  Google Scholar 

  18. Auxilium Pharmaceuticals, Inc. Press Release. “Auxilium Pharmaceuticals, Inc. announces positive data from phase 2a study of CCH in patients with cellulite.” August 21, 2014.

    Google Scholar 

  19. BioSpecifics Technologies Corp. Press Release. BioSpecifics Technologies Corp. announced positive, highly statistically significant results from a Phase 2b study of CCH for the treatment of cellulite, or edematous fibrosclerotic panniculopathy. Lynbrook, NY, November 17, 2016.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hand Surgery, Uppsala University Hospital, Uppsala, Sweden

    S. Wilbrand

Authors
  1. S. Wilbrand
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Wilbrand .

Editor information

Editors and Affiliations

  1. Hand Surgery & Rehabilitation Department-Ospedale San Giuseppe, MultiMedica Group, Milan, Italy

    Giorgio Pajardi

  2. Stony Brook University Medical Center, New York, USA

    Marie A. Badalamente

  3. Department of Orthopaedics, Stony Brook University Medical Center, New York, USA

    Lawrence C. Hurst

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wilbrand, S. (2018). Collagenase: Future Perspectives. In: Pajardi, G., Badalamente, M., Hurst, L. (eds) Collagenase in Dupuytren Disease . Springer, Cham. https://doi.org/10.1007/978-3-319-65822-3_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-65822-3_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-65821-6

  • Online ISBN: 978-3-319-65822-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation